文献速递中毒与环境急症儿科与产科急症

处方药监测计划与青少年和年轻成人阿片类药物处方及过量的关联

Association of Prescription Drug Monitoring Programs With Opioid Prescribing and Overdose in Adolescents and Young Adults.
PubMed 文献 · Ann Emerg Med · 2023-01-18
一句话结论强制性处方药监测计划审查与青少年和年轻成人阿片类药物配药及过量持续下降相关。

本研究采用中断时间序列分析,评估2008至2019年间州级实施强制性处方药监测计划(PDMP)与13至18岁青少年及19至25岁年轻成人年度阿片类药物处方和过量之间的关联,数据来自商业保险公司。在9,344,504名青少年和年轻成人中,1,405,382人(15.0%)有阿片类处方配药,6,262人(0.1%)因阿片相关过量接受治疗。强制性PDMP审查与青少年年度阿片配药减少4.2%(95%CI 1.9%至6.4%)、年轻成人减少7.8%(95%CI 4.7%至10.9%)相关;与青少年年度阿片过量减少16.1%(95%CI 3.8至26.7)、年轻成人减少15.9%(95%CI 7.6至23.4)相关。作者认为这些发现支持将强制性PDMP作为减少阿片过量的持续策略的一部分,但需前瞻性研究进一步明确其效果。

要点

  • 在9,344,504名13至25岁人群中,强制性PDMP审查与青少年年度阿片配药减少4.2%(95%CI 1.9%至6.4%)、年轻成人减少7.8%(95%CI 4.7%至10.9%)相关。
  • 强制性PDMP审查与青少年年度阿片相关过量减少16.1%(95%CI 3.8至26.7)、年轻成人减少15.9%(95%CI 7.6至23.4)相关。
  • 研究期间1,405,382人(15.0%)有阿片类处方配药,6,262人(0.1%)因阿片相关过量接受治疗。
  • 作者认为这些发现支持将强制性PDMP作为减少阿片过量的持续策略的一部分。
  • 作者指出需前瞻性研究设计来全面描述这些计划的效果。

适用人群与场景

  • 13至18岁青少年和19至25岁年轻成人,数据来自商业保险公司,研究时段为2008至2019年。

研究设计与关键结果

  • 研究类型为中断时间序列分析,纳入9,344,504名青少年和年轻成人,评估州级实施强制性PDMP审查与年度阿片处方及过量的关联。
  • 主要终点:强制性PDMP审查与青少年年度阿片配药减少4.2%(95%CI 1.9%至6.4%)、年轻成人减少7.8%(95%CI 4.7%至10.9%)相关。
  • 关键次要终点:强制性PDMP审查与青少年年度阿片相关过量减少16.1%(95%CI 3.8至26.7)、年轻成人减少15.9%(95%CI 7.6至23.4)相关。
  • 人群中1,405,382人(15.0%)有阿片类处方配药,6,262人(0.1%)因阿片相关过量接受治疗。

证据类型、等级与局限

  • 证据类型:中断时间序列分析。
  • 局限:作者指出需前瞻性研究设计来全面描述这些计划的效果。

对床旁实践的改变

  • 作者认为这些发现支持将强制性PDMP作为减少阿片过量的持续策略的一部分。
  • 作者指出需前瞻性研究设计来全面描述这些计划的效果。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: Prescription opioid use is associated with substance-related adverse outcomes among adolescents and young adults through a pathway of prescribing, diversion and misuse, and addiction and overdose. Assessing the effect of current prescription drug monitoring programs (PDMPs) on opioid prescribing and overdoses will further inform strategies to reduce opioid-related harms.

METHODS: We performed interrupted time series analyses to measure the association between state-level implementation of PDMPs with annual opioid prescribing and opioid-related overdoses in adolescents (13 to 18 years) and young adults (19 to 25 years) between 2008 and 2019. We focused on PDMPs that included mandatory reviews by providers. Data were obtained from a commercial insurance company.

RESULTS: Among 9,344,504 adolescents and young adults, 1,405,382 (15.0%) had a dispensed opioid prescription, and 6,262 (0.1%) received treatment for an opioid-related overdose. Mandated PDMP review was associated with a 4.2% (95% CI, 1.9% to 6.4%) reduction in annual opioid dispensations among adolescents and a 7.8% (95% CI, 4.7% to 10.9%) annual reduction among young adults. For opioid-related overdoses, mandated PDMP review was associated with a 16.1% (95% CI, 3.8 to 26.7) and 15.9% (95% CI, 7.6 to 23.4) reduction in annual opioid overdoses for adolescents and young adults, respectively.

CONCLUSION: PDMPs were associated with sustained reductions in opioid prescribing and overdoses in adolescents and young adults. Although these findings support the value of mandated PDMPs as part of ongoing strategies to reduce opioid overdoses, further studies with prospective study designs are needed to characterize the effect of these programs fully.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Toce MS, Michelson KA, Hudgins JD, et al. Association of Prescription Drug Monitoring Programs With Opioid Prescribing and Overdose in Adolescents and Young Adults. Ann Emerg Med. 2023. PMID: 36669914. doi:10.1016/j.annemergmed.2022.11.003

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。